Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03402139 · ClinicalTrials.gov registry record
Early Childhood Obesity Programming by Intrauterine Growth Restriction
A clinical trial of Childhood Obesity and Epigenetics, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- 400
- Enrollment target
- 1
- Study location
NCT03402139: Recruiting study of Childhood Obesity and Epigenetics, sponsored by Montefiore Medical Center.
NCT03402139 is a study of Childhood Obesity and Epigenetics that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 400 participants, below the 551-participant average among 43 other Childhood Obesity trials with a reported enrollment target (27% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03402139, a study of Childhood Obesity and Epigenetics, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased risk for obesity and other metabolic disorders in adult life.
Primary Outcome
Change in growth velocity based on DNA methylation marks and functional profiles of CD3+ T-cells
Conditions Studied
Study Locations (1)
New York
- Jack D. Weiler Hospital - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2028-03 |
What NCT03402139 shows while recruiting
NCT03402139 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 551-participant average among 43 other Childhood Obesity trials with a reported enrollment target (27% lower).
The record links to 2 conditions, with Childhood Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT03402139 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03402139 about?
NCT03402139 is a clinical study titled "Early Childhood Obesity Programming by Intrauterine Growth Restriction". The molecular mechanisms underlying developmental programming of childhood obesity remain poorly understood. Here, the investigators address major questions about early childhood obesity programming by studying CD3+ T-cells from intrauterine growth restricted (IUGR) newborns who have an increased ri...
What is the current status of trial NCT03402139?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2018-09-01. Estimated completion is 2028-03.
What conditions does trial NCT03402139 study?
This clinical trial studies the following conditions: Childhood Obesity, Epigenetics.
Who is sponsoring clinical trial NCT03402139?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03402139 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03402139's enrollment target sits among peer trials
400 12th of 43 higher than 32 of 43 other Childhood Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Family Intervention to Prevent Childhood Obesity
RECRUITING · NA
-
Integrating Food Rx With Best Feeding Practices With EFNEP
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
Genetic Risk, Parental Feeding Practices, and Appetitive Traits in Early Life
RECRUITING · NA
-
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
RECRUITING
-
Maternal Smoking Cessation and Pediatric Obesity Prevention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI